Samhita Jain

Samhita Jain

Auto-generated profile, based on publicly available information

Samhita Jain

Weill Institute for Neurosciences, University of California San Francisco, San Francisco, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
GPGalina Popova
Galina Popova
SSSarah S. Soliman
Sarah S. Soliman
CKChang N. Kim
Chang N. Kim
MKMatthew G. Keefe
Matthew G. Keefe
KHKelsey M. Hennick
Kelsey M. Hennick
TNTomasz Jan Nowakowski
Tomasz Jan Nowakowski

6 August 2025 in Nature
Verified
Journal Article
Open access
PDF file
DYDiankun Yu
Diankun Yu
SJSamhita Jain
Samhita Jain
AWAndi Wangzhou
Andi Wangzhou
BZBeika Zhu
Beika Zhu
WSWenyuan Shao
Wenyuan Shao
XPXianhua Piao
Xianhua Piao
GABAergic neurons are essential cellular components of neural circuits. Their abundance and diversity have increased significantly in the human brain, contributing to the expanded cognitive capacity of humans1. However, the developmental mechanism underlying the extended production of GABAergic neurons in the human brain remains elusive. Here we uncovered the microglial regulation of the sustained proliferation of GABAergic progenitors and neuroblasts in the human medial ganglionic eminence (hMGE). We showed that microglia are preferentially distributed in the proliferating zone and identified insulin-like growth factor 1 (IGF1) and its receptor IGR1R as the predicted top ligand–receptor pair underlying microglia–progenitor communication in the prenatal hMGE. Using our newly developed neuroimmune hMGE organoids, which mimic the hMGE cytoarchitecture and developmental trajectory, we demonstrated that microglia-derived IGF1 promotes progenitor proliferation and production of GABAergic neurons. Conversely, IGF1-neutralizing antibodies and IGF1 knockout human embryonic stem-cell-induced microglia abolish the induced microglia-mediated progenitor proliferation. Together, these findings revealed a previously unappreciated role of microglia-derived IGF1 in promoting the proliferation of neural progenitors and the development of GABAergic neurons in the human brain.

17 October 2023 in Frontiers in Pediatrics
Verified
Journal Article
Open access
SJSamhita Jain
Samhita Jain
IAIsabel Elaine Allen
Isabel Elaine Allen
DSDongli Song
Dongli Song
XPXianhua Piao
Xianhua Piao
Background: The COVID-19 pandemic has affected a significant number of pregnant women worldwide, but studies on immune responses have presented conflicting results. This study aims to systematically review cytokine profiles in pregnant women with SARS-CoV-2 infection and their infants to evaluate immune responses and potential transplacental transfer of cytokines.Materials and methods: A comprehensive search of 4 databases was conducted to identify relevant studies. Inclusion criteria included studies measuring individual cytokines in pregnant women and/or their neonates. Studies were evaluated for quality, and data were extracted for analysis. Meta-analyses were performed using the random-effects model.Results: Seventeen studies met the inclusion criteria, including data from 748 pregnant women and 287 infants. More than three of these studies evaluated data of 20 cytokines in maternal serum, and data of 10 cytokines was available from cord blood samples. Only the serum level of CXCL10 was significantly up-regulated in SARS-CoV-2 positive pregnant women (n = 339) compared to SARS-CoV-2 negative pregnant women (n = 409). Subset analysis of maternal samples (n = 183) collected during the acute phase of COVID-19 infection showed elevated CXCL10 and IFN-γ. No significant differences in cytokine levels were found between cord blood samples collected from infants born to mothers with (n = 97) and without (n = 190) COVID-19 during gestation. Subset analysis of cord blood samples collected during the acute phase of maternal infection was limited by insufficient data. The heterogeneity among the studies was substantial.Conclusion: The findings suggest that maternal cytokines responses to SARS-CoV-2 infection during pregnancy are not significantly dysregulated, except for CXCL10 and IFN-γ during the acute phase of illness. No evidence of increased cytokine levels in cord blood samples was observed, although this could be impacted by the time period between initial maternal infection and cord blood collection. These results provide some reassurance to parents and healthcare providers but should be interpreted cautiously due to study variations and limitations.

10 November 2023 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
SJSamhita Jain
Samhita Jain
SOScott Oltman
Scott Oltman
ERElizabeth Rogers
Elizabeth Rogers
KRKelli K Ryckman
Kelli K Ryckman
MPMark Petersen
Mark Petersen
LJLaura Jelliffe-Pawlowski
Laura Jelliffe-Pawlowski
Objective: To characterize the biochemical and demographic profiles of pregnant people with maternal immune activation (MIA) and identify the prenatal characteristics associated with neurologic morbidity in offspring. Study design: This was a retrospective cohort study of 602 mother-infant dyads with births between 2009 and 2010 in California. Multivariable logistic regression was used to build a MIA vulnerability profile including mid-pregnancy biochemical markers and maternal demographic characteristics, and its relationship with infant neurologic morbidity was examined. Results: Of the 602 mother-infant dyads, 80 mothers and 61 infants had diagnoses suggestive of MIA and neurologic morbidity, respectively. Our model, including two demographic and seven biochemical characteristics, identified mothers with MIA with good performance (AUC:0.814; 95% CI:0.7–0.8). Three demographic and five inflammatory markers together identified 80% of infants with neurological morbidity (AUC:0.802, 95% CI:0.7–0.8). Conclusion: Inflammatory environment in mothers with pre-existing risk factors like obesity, poverty, and prematurity renders offspring more susceptible to neurologic morbidities.

4 July 2023 in Research Square
Verified
Preprint
Open access
PDF file
SJSamhita Jain
Samhita Jain
SOScott Oltman
Scott Oltman
ERElizabeth Rogers
Elizabeth Rogers
KRKelli K Ryckman
Kelli K Ryckman
MPMark Petersen
Mark Petersen
LJLaura Jelliffe-Pawlowski
Laura Jelliffe-Pawlowski
Objective To characterize the biochemical and demographic profiles of pregnant people with maternal immune activation (MIA) and identify the prenatal characteristics associated with neurologic morbidity in offspring. Study design: This was a population-based retrospective cohort study of mother-infant dyads with births between 2009–2010 in California. Multivariable logistic regression was used to build a MIA vulnerability profile including mid-pregnancy biochemical markers and maternal demographic characteristics, and its relationship with infant neurologic morbidity was examined. Results Of the 602 mother-infant dyads, 80 mothers and 61 infants had diagnoses suggestive of MIA and neurologic morbidity, respectively. Our model, including two demographic and seven biochemical characteristics, identified mothers with MIA with good performance (AUC:0.814; 95%CI:0.7–0.8). Three demographic and five inflammatory markers together identified 80% of infants with neurological morbidity (AUC:0.802, 95%CI:0.7–0.8). Conclusion Inflammatory environment in mothers with pre-existing risk factors like obesity, poverty and prematurity renders offspring more susceptible to neurologic morbidities.